Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Ifrah

Showing results (51-60 of 169) with videos related to

Pageof 17
Sort By:
Blood|September 13, 2007
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cellsDorothée Duluc, Yves Delneste, Fang Tan, et al.
Transplantation|March 8, 2016
Different Impact of the Number of Organ Failures and Graft-Versus-Host Disease on the Outcome of Allogeneic Stem Cell Transplantation Recipients Requiring Intensive CareCorentin Orvain, Francois Beloncle, Jean-Francois Hamel, et al.
Leukemia|February 7, 2019
Peripheral blood minimal/measurable residual disease assessed in flow cytometry in acute myeloblastic leukemiaCécile Guénot, Francis Lacombe, Kaoutar Allou, et al.
British Journal of Haematology|September 29, 2012
Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) studyPauline Peyrouze, Soizic Guihard, Nathalie Grardel, et al.
British Journal of Haematology|October 15, 2011
The eukaryotic initiating factor 4E protein is overexpressed, but its level has no prognostic impact in acute myeloid leukaemiaAlexa S Green, Sophie Grabar, Micheline Tulliez, et al.
Blood|July 31, 2010
IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemiaNicolas Chapuis, Sophie Park, Laurent Leotoing, et al.
Haematologica|September 21, 2019
Low level CpG island promoter methylation predicts a poor outcome in adult T-cell acute lymphoblastic leukemiaAurore Touzart, Nicolas Boissel, Mohamed Belhocine, et al.
Blood|April 12, 2007
Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patientsJerome Tamburini, Caroline Elie, Valérie Bardet, et al.
Annals of Hematology|May 3, 2018
Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essenceCorentin Orvain, Francois Beloncle, Jean-Francois Hamel, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 11, 2004
Developing a European network for adult ALLNicola Gökbuget, Renato Bassan, Adriaan Dekker, et al.
Pageof 17

Showing results (51-60 of 169) with videos related to

Sort By:
Pageof 17
Blood|September 13, 2007
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cellsDorothée Duluc, Yves Delneste, Fang Tan, et al.
Transplantation|March 8, 2016
Different Impact of the Number of Organ Failures and Graft-Versus-Host Disease on the Outcome of Allogeneic Stem Cell Transplantation Recipients Requiring Intensive CareCorentin Orvain, Francois Beloncle, Jean-Francois Hamel, et al.
Leukemia|February 7, 2019
Peripheral blood minimal/measurable residual disease assessed in flow cytometry in acute myeloblastic leukemiaCécile Guénot, Francis Lacombe, Kaoutar Allou, et al.
British Journal of Haematology|September 29, 2012
Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) studyPauline Peyrouze, Soizic Guihard, Nathalie Grardel, et al.
British Journal of Haematology|October 15, 2011
The eukaryotic initiating factor 4E protein is overexpressed, but its level has no prognostic impact in acute myeloid leukaemiaAlexa S Green, Sophie Grabar, Micheline Tulliez, et al.
Blood|July 31, 2010
IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemiaNicolas Chapuis, Sophie Park, Laurent Leotoing, et al.
Haematologica|September 21, 2019
Low level CpG island promoter methylation predicts a poor outcome in adult T-cell acute lymphoblastic leukemiaAurore Touzart, Nicolas Boissel, Mohamed Belhocine, et al.
Blood|April 12, 2007
Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patientsJerome Tamburini, Caroline Elie, Valérie Bardet, et al.
Annals of Hematology|May 3, 2018
Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essenceCorentin Orvain, Francois Beloncle, Jean-Francois Hamel, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 11, 2004
Developing a European network for adult ALLNicola Gökbuget, Renato Bassan, Adriaan Dekker, et al.
Pageof 17